Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
收藏Protein Data Bank Japan2024-11-20 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/6usz
下载链接
链接失效反馈官方服务：
资源简介：
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer Descriptor: GTPase KRas, GUANOSINE-5'-DIPHOSPHATE, MAGNESIUM ION, ... Authors: Vigers, G.P, Smith, D.J. Deposit date: 2019-10-28 Release date: 2020-04-22 Last modified: 2024-11-20 Method: X-RAY DIFFRACTION (2.03 Å) Cite: Identification of the Clinical Development CandidateMRTX849, a Covalent KRASG12CInhibitor for the Treatment of Cancer. J.Med.Chem., 63, 2020
创建时间：
2019-10-28
